IMMUNE "OCULAR SURFACE PROPERTIES AND RESPONSE IN PARKINSON'S DISEASE PATIENTS UNDERGOING AND NOT UNDERGOING TREATMENT"

Parkinson's illness (PD) is a central nervous system neurodegenerative condition that progresses over time.One of the nonmotor impairments that is most frequently mentioned is visual disturbance.in people with early-stage Parkinson's condition.Furthermore, Reduced blinking and dry eyes are two common ocular surface abnormalities Among those suffering from Parkinson's disease (PD).Tears from PD individuals exhibit particular protein composition-related abnormalities, and Confocal imaging in vivo has demonstrated notable alterations in numerous corneal layers in this scenario.Both the sickness and the medications used to treat it can be blamed for these changes.The indicators of ocular toxicity in PD patients using amantadine, in the literature, both at the endothelium and epithelial levels, are exceptionally well defined.Immunomodulatory therapeutic methods that try to reduce Parkinson's disease neurodegeneration are becoming increasingly intriguing and should be researched further.Knowing the typical, but frequently undiagnosed, from the standpoint of the ophthalmologist, modifications to Critical to the care of individuals with the disorder on the ocular surface ,warning indicators of drug toxicity.Ocular surface markers may also be helpful in diagnosing .early detection of the neurological disorder Parkinson's (PD) and tracking the progression of brain deterioration over time.